A joint report released today by Dr. Steven Spandorfer of Weill Cornell Medicine and Sital Kalantry of Cornell Law School examines the medical and legal elements of gestational surrogacy.
Memorial Sloan Kettering Cancer Center (MSK), The Rockefeller University, and Weill Cornell Medicine today announced that the Tri-Institutional Therapeutics Discovery Institute, Inc. (Tri-I TDI) has renewed its collaborations with partners Takeda Pharmaceutical Company Limited (Takeda) and Bridge Medicines.
Dr. Tan A. Ince has been named chief of pathology at NewYork-Presbyterian Brooklyn Methodist Hospital, effective February 1. Dr. Ince was also recruited to Weill Cornell Medicine as a professor of pathology and laboratory medicine.
Dr. Vivian J. Bea, an expert in breast cancer disparities, has been named section chief of breast surgical oncology at NewYork-Presbyterian Brooklyn Methodist Hospital. She also serves as an assistant professor of surgery at Weill Cornell Medicine.
A transformative new scholarship program established by Weill Cornell Medicine will eliminate medical education debt for all students who qualify for financial aid.
Dr. Laura Alonso has been named chief of the Division of Endocrinology, Diabetes and Metabolism at Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center, effective Sept. 1. Dr. Alonso will also lead the Joan and Sanford I. Weill Center for Metabolic Health at Weill Cornell Medicine.
Dr. Nir Uriel, a renowned leader in the field of heart failure, mechanical circulatory support and heart transplantation, has been appointed director of advanced heart failure and cardiac transplantation at NewYork-Presbyterian, effective August 16.
NewYork-Presbyterian Hospital is ranked No. 5 in the nation and No. 1 in New York, according to U.S. News and World Report’s annual survey of “Best Hospitals,” published online today.
Dr. Alfred C. Winkler has been named chief of urology at NewYork-Presbyterian Brooklyn Methodist Hospital. Dr. Winkler, who is also an assistant professor of clinical urology at Weill Cornell Medicine, was most recently chief of urology at NewYork-Presbyterian Lower Manhattan Hospital.
The Starr Foundation is continuing its longstanding commitment to stem cell research in New York City with a $50 million gift in support of the Tri-Institutional Stem Cell Initiative (Tri-SCI), a research collaboration between Memorial Sloan Kettering Cancer Center, The Rockefeller University and Weill Cornell Medicine.
Consuming the equivalent of one can of soda per day caused mice predisposed to colon cancer to develop larger tumors, according to a study by Weill Cornell Medicine and NewYork-Presbyterian investigators.
Dr. Helen Su, a clinical immunologist who has made key discoveries into the genetic causes of rare immune system diseases in children, has been awarded the fourth annual Gale and Ira Drukier Prize in Children’s Health Research.
Dr. Manuel Hidalgo, a leading physician-scientist who specializes in pancreatic cancer and drug development, has been named chief of the Division of Hematology and Medical Oncology in the Weill Department of Medicine at Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center, effective June 1.
Dr. Barbara Hempstead, a preeminent physician-scientist, educator and academic leader, has been appointed dean of the Weill Cornell Graduate School of Medical Sciences, effective Jan. 14.
Dr. Massimo Loda Appointed Chair of the Department of Pathology and Laboratory Medicine at Weill Cornell Medicine and Pathologist-in-Chief at NewYork-Presbyterian/Weill Cornell Medical Center
Dr. Lisa Newman, an internationally renowned breast surgeon and researcher, has been appointed chief of the Section of Breast Surgery at NewYork-Presbyterian/Weill Cornell Medical Center and Weill Cornell Medicine, effective Aug. 20.
Dr. Francis Lee, a leading physician-scientist whose research focuses on anxiety disorders, has been named chairman of the Department of Psychiatry at Weill Cornell Medicine and psychiatrist-in-chief at NewYork-Presbyterian/Weill Cornell Medical Center, effective July 1.
A very low carbohydrate, high-fat diet called the ketogenic diet may improve the effectiveness of an emerging class of cancer drugs, according to a study in mice by investigators at Weill Cornell Medicine, Columbia University Irving Medical Center and NewYork-Presbyterian.
